Search

Coloplast A-S (Class B)

Fechado

588 -1.87

Visão Geral

Variação de preço das ações

24h

Atual

Mín

587

Máximo

590

Indicadores-chave

By Trading Economics

Rendimento

-107M

805M

Vendas

28M

7B

P/E

Médio do Setor

37.127

105.69

EPS

4.67

Rendimento de Dividendos

3.83

Margem de lucro

11.569

Funcionários

16,744

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

+11.86% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

3.83%

2.37%

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-5B

132B

Abertura anterior

589.87

Fecho anterior

588

Coloplast A-S (Class B) Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

14 de nov. de 2025, 17:45 UTC

Ganhos
Grandes Movimentos do Mercado

Figure Technology Shares Rise After Higher 3Q Earnings, Revenue

14 de nov. de 2025, 17:31 UTC

Ganhos
Grandes Movimentos do Mercado

American Bitcoin Advances on 3Q Profit, Eric Trump's Crypto Confidence

15 de nov. de 2025, 18:03 UTC

Ganhos

Kugler Resignation From Fed Board Followed Disclosures of Improper Stock Trades -- UPDATED -- WSJ

15 de nov. de 2025, 15:43 UTC

Ganhos

Kugler Resignation From Fed Board Followed Disclosures of Improper Stock Trades -- WSJ

15 de nov. de 2025, 12:00 UTC

Ganhos

Meta Opens Pop-Up Stores to Build Buzz for Its AI Glasses -- WSJ

15 de nov. de 2025, 09:20 UTC

Conversa de Mercado
Ganhos

Tech, Media & Telecom Roundup: Market Talk

15 de nov. de 2025, 09:20 UTC

Conversa de Mercado

Energy & Utilities Roundup: Market Talk

15 de nov. de 2025, 00:08 UTC

Aquisições, Fusões, Aquisições de Empresas

Berkshire Buys Shares of Alphabet and Further Pares Apple Stake -- 3rd Update

14 de nov. de 2025, 23:56 UTC

Aquisições, Fusões, Aquisições de Empresas

Berkshire Hathaway Bought Alphabet Shares Worth $4.3 Billion in the Third Quarter. Here's What It Sold. -- Barrons.com

14 de nov. de 2025, 23:02 UTC

Conversa de Mercado

Chinese Battery Makers Benefit From U.S. Rising Demand -- Market Talk

14 de nov. de 2025, 22:35 UTC

Ganhos
Aquisições, Fusões, Aquisições de Empresas

The Score: Tyson, Robinhood, Walmart, Paramount Skydance and More Stocks That Defined the Week -- WSJ

14 de nov. de 2025, 22:32 UTC

Aquisições, Fusões, Aquisições de Empresas

Berkshire Buys Shares of Alphabet and Further Pares Apple Stake -- 2nd Update

14 de nov. de 2025, 22:29 UTC

Ganhos

Starbucks Scores on Holiday Sales. It's a Good Sign for the Turnaround. -- Barrons.com

14 de nov. de 2025, 22:00 UTC

Aquisições, Fusões, Aquisições de Empresas

Berkshire Buys Shares of Alphabet and Further Pares Apple Stake -- Update

14 de nov. de 2025, 21:50 UTC

Conversa de Mercado
Ganhos

Tech, Media & Telecom Roundup: Market Talk

14 de nov. de 2025, 21:18 UTC

Aquisições, Fusões, Aquisições de Empresas

Berkshire Buys Shares of Alphabet and Pares Apple Stake -- WSJ

14 de nov. de 2025, 20:27 UTC

Conversa de Mercado

Oil Futures Rise After Ukraine Strikes Russian Port -- Market Talk

14 de nov. de 2025, 20:23 UTC

Conversa de Mercado

U.S. Natural Gas Futures Post Weekly Gain -- Market Talk

14 de nov. de 2025, 20:17 UTC

Aquisições, Fusões, Aquisições de Empresas

Several State Attorneys General Oppose Railroad Merger -- WSJ

14 de nov. de 2025, 19:29 UTC

Conversa de Mercado
Ganhos

Applied Materials' F4Q Results Seen as 'Uninspiring' -- Market Talk

14 de nov. de 2025, 18:44 UTC

Conversa de Mercado
Ganhos

Disney's Growth Now Hinges More on ESPN -- Market Talk

14 de nov. de 2025, 18:27 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

14 de nov. de 2025, 18:27 UTC

Conversa de Mercado

Morgan Stanley Sees 'Worthy Successor' in Walmart CEO Furner -- Market Talk

14 de nov. de 2025, 18:20 UTC

Conversa de Mercado

U.S. Oil Rig Count Rises by 3 to 417 -- Market Talk

14 de nov. de 2025, 17:20 UTC

Conversa de Mercado
Ganhos

Auto & Transport Roundup: Market Talk

14 de nov. de 2025, 17:20 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Health Care Roundup: Market Talk

14 de nov. de 2025, 17:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

14 de nov. de 2025, 16:51 UTC

Conversa de Mercado

Starbucks Gets Holiday Sales Lift -- Market Talk

14 de nov. de 2025, 16:48 UTC

Conversa de Mercado

Gold Slides Amid Selloff, Lower December Fed Rate-Cut Expectations -- Market Talk

14 de nov. de 2025, 16:38 UTC

Conversa de Mercado

Unica Reports Higher Brazilian Sugar and Ethanol Production -- Market Talk

Coloplast A-S (Class B) Previsão

Preço-alvo

By TipRanks

11.86% parte superior

Previsão para 12 meses

Média 901.38 DKK  11.86%

Máximo 1,056 DKK

Mínimo 720 DKK

Com base em 8 analistas de Wall Street que oferecem metas de preço de 12 meses para Coloplast A-S (Class B) - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

8 ratings

2

Comprar

4

Manter

2

Vender

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat